on Cantourage Group SE (isin : DE000A3DSV01)
Cantourage Group SE Reports 118% Sales Increase in 2024 Amid Cannabis Legalization
Cantourage Group SE, a leading European cannabis company, reported a 118% rise in sales in 2024, reaching EUR 51.4 million. This figure surpasses their forecast, reflecting significant growth driven by the legalization of cannabis in Germany and an increased demand in both Germany and the UK.
The company achieved record-breaking sales in December 2024 and the fourth quarter, amounting to EUR 8.5 million and EUR 21.2 million, respectively. This success is attributed to the expanded processing capacities, meeting the rising demand for cannabis-based pharmaceuticals.
CEO Philip Schetter highlighted the economic potential unlocked by partial legalization and shared plans for further growth through new ventures in Poland and expanded telemedicine services in 2025. Cantourage aims to leverage its asset-light model for sustainable growth and increased profitability in the European market.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Cantourage Group SE news